Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Deposition of superparamagnetic iron-oxide nanoparticles in axillary sentinel lymph nodes following subcutaneous injection.

Johnson L, Pinder SE, Douek M.

Histopathology. 2013 Feb;62(3):481-6. doi: 10.1111/his.12019. Epub 2012 Dec 21.

PMID:
23278862
2.

Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.

Shimazu K, Tamaki Y, Taguchi T, Akazawa K, Inoue T, Noguchi S.

Cancer. 2004 Jun 15;100(12):2555-61.

3.

Sentinel node biopsy in ductal carcinoma in situ patients.

Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS.

Ann Surg Oncol. 2000 Jan-Feb;7(1):15-20.

PMID:
10674443
4.

The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma.

Olszewski WP, Szumera-Ciećkiewicz A, Piechocki J, Towpik E, Olszewski WT.

Pol J Pathol. 2009;60(3):138-43.

5.

Predictors of non-sentinel lymph node metastasis in breast cancer patients.

Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE; ALMANAC Trialists Group.

Eur J Cancer. 2004 Jul;40(11):1731-7.

PMID:
15251163
6.

Second echelon node predicts metastatic involvement of additional axillary nodes following sentinel node biopsy in early breast cancer.

Bassi KK, Seenu V, Ballehaninna UK, Parshad R, Chumber S, Dhar A, Gupta SD, Kumar R, Srivastava A.

Indian J Cancer. 2006 Jul-Sep;43(3):103-9.

7.

Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol.

Pouw JJ, Grootendorst MR, Bezooijen R, Klazen CA, De Bruin WI, Klaase JM, Hall-Craggs MA, Douek M, Ten Haken B.

Br J Radiol. 2015;88(1056):20150634. doi: 10.1259/bjr.20150634. Epub 2015 Oct 22.

8.

Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.

Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA.

Am J Surg Pathol. 2000 Sep;24(9):1266-72.

PMID:
10976701
9.
10.

Histopathologic analysis of sentinel lymph nodes in breast carcinoma.

Hsieh PP, Ho WL, Yeh DC, Liu TJ, Wu CC, Lin JH, Wang SJ.

Zhonghua Yi Xue Za Zhi (Taipei). 2000 Oct;63(10):744-50.

PMID:
11076431
11.

Prognostic and therapeutic impact of sentinel node micrometastasis in patients with invasive breast cancer.

Carcoforo P, Bergossi L, Basaglia E, Soliani G, Querzoli P, Zambrini E, Pozza E, Feggi L.

Tumori. 2002 May-Jun;88(3):S4-5.

PMID:
12365385
12.

Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.

Pendas S, Dauway E, Cox CE, Giuliano R, Ku NN, Schreiber RH, Reintgen DS.

Am Surg. 1999 Jun;65(6):500-5; discussion 505-6.

PMID:
10366202
13.

Utility of the GeneSearch breast lymph node assay for the rapid evaluation of sentinel lymph nodes in breast cancer.

Funasako Y, Uenosono Y, Hirata M, Arigami T, Yanagita S, Arima H, Ehi K, Kijima Y, Yoshinaka H, Natsugoe S.

Cancer. 2010 Oct 1;116(19):4450-5. doi: 10.1002/cncr.25479.

14.

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR.

Breast J. 2003 May-Jun;9(3):153-62.

PMID:
12752622
15.
16.

Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.

Takeshita T, Tsuda H, Moriya T, Yamasaki T, Asakawa H, Ueda S, Sato K, Aida S, Tamai S, Matsubara O, Hase K, Yamamoto J.

Ann Surg Oncol. 2012 Apr;19(4):1160-6. doi: 10.1245/s10434-011-2085-5. Epub 2011 Oct 12.

PMID:
21989659
17.

The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer.

Wong SL, Chao C, Edwards MJ, Simpson D, McMasters KM; University of Louisville Breast Cancer Study Group.

Am J Surg. 2001 Oct;182(4):330-4.

PMID:
11720665
18.

Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma.

Viale G, Maiorano E, Mazzarol G, Zurrida S, Galimberti V, Luini A, Renne G, Pruneri G, Maisonneuve P, Veronesi U.

Cancer. 2001 Sep 15;92(6):1378-84.

PMID:
11745213
19.

Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.

Altinyollar H, Kapucuoglu N, Pak I, Berberoglu U.

J Exp Clin Cancer Res. 2000 Jun;19(2):141-4.

PMID:
10965808
20.

Discordance of intraoperative frozen section analysis with definitive histology of sentinel lymph nodes in breast cancer surgery: complementary axillary lymph node dissection is irrelevant for subsequent systemic therapy.

Geertsema D, Gobardhan PD, Madsen EV, Albregts M, van Gorp J, de Hooge P, van Dalen T.

Ann Surg Oncol. 2010 Oct;17(10):2690-5. doi: 10.1245/s10434-010-1052-x. Epub 2010 Apr 27.

Supplemental Content

Support Center